Home › Cardiovascular Disease › Michigan › Flint
Cardiovascular Disease clinical trials in Flint, MI
3 studies for Cardiovascular Disease are looking for participants at sites in and around Flint (within about 30 miles). Open a study to see who can join and how to contact the study team.
EASi-PROTKT™ - A Study to Test Vicadrostat (BI 690517) Taken Together With Empagliflozin in People With Type 2 Diabetes, High Blood Pressure, and Cardiovascular Disease
RecruitingPhase 3
- Aa Mrc Llc, Flint
- Elite Research Center, LLC, Flint
Zilebesiran in Patients With Hypertension Not Adequately Controlled and With Either Established Cardiovascular Disease or High Risk for Cardiovascular Disease
RecruitingPhase 3
- Clinical Trial Site, Flint
An Open Label Extension (OLE) Study (Following Completion of CTQJ230A12301) to Evaluate Long-term Safety and Tolerability of Pelacarsen (TQJ230)
RecruitingPhase 3
- AA Medical Research Center, Flint
Cardiovascular Disease trials in other cities
- Boston, MA36 studies
- New York City, NY32 studies
- Washington, DC29 studies
- Houston, TX24 studies
- Dallas, TX23 studies
- Cleveland, OH22 studies
- Atlanta, GA22 studies
- Philadelphia, PA21 studies
- Chicago, IL21 studies
- St. Louis, MO20 studies
- Pittsburgh, PA20 studies
- Nashville, TN19 studies
Other studies in Flint
- Lung Cancer10 studies
- Breast Cancer9 studies
- Non-Small Cell Lung Cancer9 studies
- Prostate Cancer7 studies
- Colorectal Cancer6 studies
- Cancer (all types)6 studies
- Acute Myeloid Leukemia6 studies
- Head and Neck Squamous Cell Carcinoma4 studies
- Hypopharyngeal Cancer4 studies
- Laryngeal Cancer4 studies
- Oral Cancer4 studies
- Lupus4 studies
From ClinicalTrials.gov, data retrieved Oct 1, 2026. Each study sets its own eligibility; the study team decides who can join.